Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-09
1999-01-12
Kelly, C. H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514397, 514825, 5483351, 548342, 544300, A61K 31415, C07D23354, C07D23356, C07D40102
Patent
active
058590412
ABSTRACT:
Compounds represented by formula I: ##STR1## are disclosed. .sup.AR represents an aromatic group containing 6-10 atoms; and ##STR2## represents a 4 to 10 membered non-aromatic heterocycle containing at least one N atom, and optionally containing 1-2 additional N atoms and 0-1 O or S atom. A pharmaceutical composition is also included. Methods of treating cancer and cytokine mediated diseases are also included.
REFERENCES:
patent: 3707475 (1972-12-01), Lombardino et al.
patent: 3772441 (1973-11-01), Lombardino et al.
patent: 3929807 (1975-12-01), Fitzi
patent: 3940486 (1976-02-01), Fitzi
J. L. Adams, Chem. Abs. 126 (12, Abs No. 126:144274K, 1997).
Bilodeau Mark T.
Butcher John W.
Claremon David A.
Liverton Nigel J.
Daniel Mark R.
Kelly C. H.
Korsen Elliott
Merck & Co. , Inc.
LandOfFree
Substituted imidazoles having cytokine inhibitory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazoles having cytokine inhibitory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazoles having cytokine inhibitory activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516416